|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Recovery of novel bacterial diversity from mangrove sediment显示文摘 | Liang JB Chen YQ Lan CY Tan NFY Zan QJ Huang LN | 2007 | 中国生物学文摘2007，21，7： | 7 |
| 2 | VIP immunoreactive nerves and somatostatin and serotonin containing cellsin Crohn′s disease显示文摘 | Lu SJ Liu YQ Lin JS Wu HJ Sun YH Tan YB | 1999 | World Journal of Gastroenterology1999，5，6： | 4 |
| 3 | Cilostazol for secondary stroke prevention:systematic review and meta-analysis显示文摘Background Stroke is one of the leading causes of death worldwide.Cilostazol,an antiplatelet and phosphodiesterase 3 inhibitor,has not been clearly established for ischaemic stroke use.We aim to determine the efficacy and safety of cilostazol for secondary stroke prevention.Methods MEDLINE,EMBASE,Cochrane Library,Web of Science and ClinicalTrials.gov were searched from inception to 25 September 2020,for randomised trials comparing the efficacy and safety of cilostazol monotherapy or dual therapy with another antiplatelet regimen or placebo,in patients with ischaemic stroke.Version 2 of the Cochrane risk-of-bias tool for randomised trials(RoB 2)was used to assess study quality.This meta-analysis was reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses(PRISMA)statement.Results Eighteen randomised trials comprising 11429 participants were included in this meta-analysis.Most trials possessed low risk of bias and were of low heterogeneity.Cilostazol significantly reduced the rate of ischaemic stroke recurrence(risk ratio,RR=0.69,95%CI 0.58 to 0.81),any stroke recurrence(RR=0.64,95%CI 0.54 to 0.74)and major adverse cardiovascular events(RR=0.67,95%CI 0.56 to 0.81).Cilostazol did not significantly decrease mortality(RR=0.90,95%CI 0.64 to 1.25)or increase the rate of good functional outcome(Modified Rankin Scale score of 0–1;RR=1.07,95%CI 0.95 to 1.19).Cilostazol demonstrated favourable safety profile,significantly reducing the risk of intracranial haemorrhage(RR=0.46,95%CI 0.31 to 0.68)and major haemorrhagic events(RR=0.49,95%CI 0.34 to 0.70).Conclusions Cilostazol demonstrated superior efficacy and safety profiles compared with traditional antiplatelet regimens such as aspirin and clopidogrel for secondary stroke prevention but does not appear to affect functional outcomes.Future randomised trials can be conducted outside East Asia,or compare cilostazol with a wider range of antiplatelet agents. | Choon Han Tan Andrew GR Wu Ching-Hui Sia Aloysius ST Leow Bernard PL Chan Vijay Kumar Sharma Leonard LL Yeo Benjamin YQ Tan | 2021 | Stroke & Vascular Neurology2021，6，3： | 2 |
| 4 | Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen显示文摘 | Tan GH Wei YQ Tian L | 2004 | Eur J Immunol2004，34，7： | 1 |
| 5 | Genetic changes in human fetuses from spontaneous abortion after in vitro fertilization detected by comparative genomic hybridization 显示文摘 | Tan YQ Hu L Lin G | 2004 | Biol Reprod2004，70，： | 1 |
| 6 | Degradation of petroleum hydrocarbons (C6-C40) and crude oil by a novel Dietzia strain 显示文摘 | Wang XB Chi CQ Nie Y Tang YQ Tan Y Wu G Wu XL | 2011 | Bioresour Technol2011，102，17： | 1 |
| 7 | Effect and mechanismof active fraction A of Guizhi Decoction on Dualdirectional Thermoregulation-Effect on prostaglandin E2 in hypothalamus of rats显示文摘 | Tan YQ Li XQ Huo HR et a1 | 1998 | Chin J Exp Tradit Med Form(中国实验方剂学杂志)1998，4，： | 1 |
| 8 | Genetic changes in human fetuses from spontaneousabortion after in vitro fertilization detected by comparative genomichybridization显示文摘 | Tan YQ Hu L Lin G | | 0，，： | 1 |
| 9 | Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen显示文摘 | TAN GH WEI YQ LING TIAN L | 2004 | Eur J Immunol2004，34，7： | 1 |
| 10 | Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities显示文摘 | Tan GH Tian L Wei YQ | 2004 | Int J Cancer2004，112，4： | 1 |
| 11 | Modeling and prediction of the mixed-mode retention mechanisms for puerarin and its analogues on n-octylamine modified poly(glycidyl methacrylate-co-ethylene glycol dimethacrylate)monoliths显示文摘 | Lv YQ Tan TW | 2009 | Process Biochemistry2009，44，11： | 1 |
| 12 | Prevalence and spectrum of GATA6 mutations associated with familial atrial fibrillation显示文摘 | Yang YQ Wang XH Tan HW | 2012 | Int J Cardiol2012，155，3： | 1 |
| 13 | Etiologi- cal Analysis of Neurode velopmental Disabilities : Single - Center Eight -Year Clinical Experience in South China显示文摘 | Guo L Li BX Deng M Wen F Jiang JH Tan YQ | 2011 | J Biomed Biotechnol2011，2，31： | 1 |
| 14 | Molecular imprinting of proteins in polymers attached to the surface of nanomaterials for selective recognition of biomacromolecules 显示文摘 | Lv YQ Tan TW Svec F | 2013 | Biotech Adv2013，31，8： | 1 |
| 15 | TFF3 modulates NF-{kappa}B and a novel nega-tive regulatory molecule of NF-{kappa}B in intestinal epithelialcells via a mechanism distinct from TNF-{alpha}显示文摘 | Zhu YQ Tan XD | 2005 | Am J PhysiolCell Physiol2005，289，5： | 1 |
| 16 | Etio- logical analysis of neurodevelopmental disabilities: single-center eight-year clinical experience in South China显示文摘 | Guo L Li BX Deng M Wen F Jiang JH Tan YQ | 2011 | J Biomed Bio- technol2011，2011，31： | 1 |
| 17 | Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers显示文摘 | Tan YQ Tan K Zhang SP | | 0，，9： | 1 |
| 18 | TFF3modulates NF-κB and a novel negative regulatory molecule of NF-κB in intestinal epithelial cells via a mechanism distinct from TNF-α显示文摘 | ZHU YQ TAN XD | 2005 | Physiol Cell2005，289，5： | 1 |
| 19 | Single-nucleotide polymorphism mieroarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers显示文摘 | Tan YQ Tan K Zhang SP | 2013 | Hum Reprod2013，28，9： | 1 |
| 20 | Degradation of petroleum hydrocarbons (C6-C40) and crude oil by a novel Dietzia strain 显示文摘 | Wang XB Chi CQ Nie Y Tang YQ Tan Y Wu G Wu XL | 2011 | Bioresour Technol2011，102，17： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员